Walgreens is expanding its specialty pharmacy services to offer gene and cell therapy services, supported by a dedicated 18,000-square-foot center in Pittsburgh, the company announced Thursday.

Walgreens’ new gene and cell therapy business will operate under a newly launched segment called Walgreens Specialty Pharmacy, which was also announced today and now houses the company’s four ...

Originally published by Walgreens Boots Alliance Walgreens Specialty Pharmacy combines existing specialty assets, fully integrates AllianceRx and represents the company’s latest step to leverage its ...

Walgreens Boots Alliance (NASDAQ:WBA) has expanded its specialty pharmacy services with a unit dedicated to gene and cell therapy services, the company announced late Wednesday. Effective Aug. 1 ...

Walgreens said it will start working directly with drugmakers to bring cell and gene therapies to U.S. patients as part of a broader effort to expand its specialty pharmacy services.

Walgreens Specialty Pharmacy introduces a comprehensive suite of services, including gene and cell therapy solutions, marking a significant advancement in the company’s healthcare offerings.

Walgreens Specialty Pharmacy has more than 1,500 specialty-trained pharmacists, 5,000 patient advocacy support team members and ten dedicated Specialty360 teams that support all specialty ...

Gene and Cell Services Pharmacy and Innovation Center — a dedicated 18,000-sq.-ft. center in Pittsburgh, Pa., with services and capabilities for these emerging therapies, including innovative ...